Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccine-derived polioviruses.

Vadim I Agol1

  • 1M.P. Chumakov Institute of Poliomyelitis and Viral Encephalitides, Russian Academy of Medical Sciences, Russia. agol@belozersky.msu.ru

Biologicals : Journal of the International Association of Biological Standardization
|May 3, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The p48 isoform of the PA2G4/EBP1/ITAF45 oncoprotein is required for the encephalomyocarditis virus IRES-driven translation initiation.

Nucleic acids research·2025
Same author

Existence and significance of viral nonreplicative RNA recombination.

PLoS biology·2023
Same author

Non-Canonical Translation Initiation Mechanisms Employed by Eukaryotic Viral mRNAs.

Biochemistry. Biokhimiia·2021
Same author

The Baltimore Classification of Viruses 50 Years Later: How Does It Stand in the Light of Virus Evolution?

Microbiology and molecular biology reviews : MMBR·2021
Same author

Polio eradication at the crossroads.

The Lancet. Global health·2021
Same author

In pursuit of intriguing puzzles.

Virology·2019

The oral poliovirus vaccine (OPV) poses risks of reversion to virulent strains, potentially causing outbreaks after its use ends. New vaccines or drugs are needed for safe polio eradication, not OPV cessation.

Area of Science:

  • Virology
  • Vaccinology
  • Public Health

Background:

  • Oral poliovirus vaccine (OPV) is highly effective but genetically unstable.
  • OPV can revert to virulent strains, especially in low-immunity populations.

Purpose of the Study:

  • To evaluate the risks associated with the planned cessation of OPV use in poliovirus eradication.
  • To highlight the need for alternative strategies to ensure safe polio eradication.

Main Methods:

  • Analysis of OPV genetic instability and reversion patterns.
  • Assessment of risks during the poliovirus eradication endgame strategy.

Main Results:

  • OPV derivatives can persist and evolve, posing a risk of outbreaks in non-immune populations.

Related Experiment Videos

  • Cessation of OPV before alternatives are available presents an unacceptable risk of polio resurgence.

    • Conclusions:

    • The current strategy for polio eradication endgame carries a high risk of outbreaks from OPV derivatives.
    • Safe discontinuation of OPV requires new vaccines or antiviral drugs and continued research.